Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's disease: Critical role of the restoration of neuronal circuits

被引:5
|
作者
Pinky [1 ]
Neha [1 ]
Ali, Mubashshir [1 ]
Tiwari, Prachi [2 ]
Alam, Mohammad Mumtaz [3 ]
Hattiwale, Haroonrashid M. [4 ]
Jamal, Azfar [5 ,6 ]
Parvez, Suhel [1 ]
机构
[1] Jamia Hamdard, Sch Chem & Life Sci, Dept Toxicol, New Delhi 110062, India
[2] Jamia Hamdard, Sch Nursing Sci & Allied Hlth, Dept Physiotherapy, New Delhi 110062, India
[3] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut Chem, Drug Design & Med Chem Lab, New Delhi 110062, India
[4] Majmaah Univ, Coll Med, Dept Basic Med Sci, Al Majmaah 11952, Saudi Arabia
[5] Majmaah Univ, Coll Sci Al Zul, Dept Biol, Al Majmaah 11952, Saudi Arabia
[6] Majmaah Univ, Hlth & Basic Sci Res Ctr, Al Majmaah 11952, Saudi Arabia
关键词
Alzheimer's disease; Oxidative stress; Synaptic plasticity; Mitochondrial dysfunction; Antioxidant; Inflammatory pathways; TRANSCRIPTION FACTOR NRF2; FACTOR-KAPPA-B; OXIDATIVE-STRESS; SIGNALING PATHWAY; MOUSE MODEL; PROTEIN; ACTIVATION; BRAIN; INJURY; INHIBITION;
D O I
10.1016/j.arr.2023.102069
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Learning and memory storage are the fundamental activities of the brain. Aberrant expression of synaptic molecular markers has been linked to memory impairment in AD. Aging is one of the risk factors linked to gradual memory loss. It is estimated that approximately 13 million people worldwide will have AD by 2050. A massive amount of oxidative stress is kept under control by a complex network of antioxidants, which occasionally fails and results in neuronal oxidative stress. Increasing evidence suggests that ROS may affect many pathological aspects of AD, including A beta accumulation, tau hyperphosphorylation, synaptic plasticity, and mitochondrial dysfunction, which may collectively result in neurodegeneration in the brain. Further investigation into the relationship between oxidative stress and AD may provide an avenue for effective preservation and pharmacological treatment of this neurodegenerative disease. In this review, we briefly summarize the cellular mechanism underlying A beta induced synaptic dysfunction. Since oxidative stress is common in the elderly and may contribute to the pathogenesis of AD, we also shed light on the role of antioxidant and inflammatory pathways in oxidative stress adaptation, which has a potential therapeutic target in neurodegenerative diseases.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA
    Reza-Zaldivar, Edwin Estefan
    Hernandez-Sapiens, Mercedes Azucena
    Minjarez, Benito
    Gomez-Pinedo, Ulises
    Sanchez-Gonzalez, Victor Javier
    Marquez-Aguirre, Ana Laura
    Canales-Aguirre, Alejandro Arturo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [42] Amyloid precursor protein - From synaptic plasticity to Alzheimer's disease
    Mileusnic, R
    Lancashire, CL
    Rose, SPR
    BIOPHYSICS FROM MOLECULES TO BRAIN: IN MEMORY OF RADOSLAV K. ANDJUS, 2005, 1048 : 149 - 165
  • [43] Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease
    Small, David H.
    Fodero, Lisa R.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (05) : 349 - 355
  • [44] Assessing the cognitive impact of neuronal and synaptic Alzheimer's disease pathology
    Giannakopoulos, Panteleinion
    NEUROBIOLOGY OF AGING, 2008, 29 : S10 - S10
  • [45] Neurophysiological biomarkers of Alzheimer's disease: In vivo evaluation of synaptic dysfunction
    Motolese, Francesco
    Dubbioso, Raffaele
    Ranieri, Federico
    Di Lazzaro, Vincenzo
    ALZHEIMERS & DEMENTIA, 2024, 20 (12) : 9082 - 9084
  • [46] Molecular Biomarkers for Diagnosis & Therapies of Alzheimer's Disease
    Potdar, Pravin D.
    Shetti, Aashutosh U.
    AIMS NEUROSCIENCE, 2016, 3 (04) : 433 - 453
  • [47] Molecular biomarkers of Alzheimer's disease: progress and prospects
    Lashley, Tammaryn
    Schott, Jonathan M.
    Weston, Philip
    Murray, Christina E.
    Wellington, Henny
    Keshavan, Ashvini
    Foti, Sandrine C.
    Foiani, Martha
    Toombs, Jamie
    Rohrer, Jonathan D.
    Heslegrave, Amanda
    Zetterberg, Henrik
    DISEASE MODELS & MECHANISMS, 2018, 11 (05)
  • [48] Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits
    Calabresi, Paolo
    Galletti, Francesca
    Saggese, Emanuele
    Ghiglieri, Veronica
    Picconi, Barbara
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S259 - S262
  • [49] Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease
    Milosevic, Luka
    Kalia, Suneil K.
    Hodaie, Mojgan
    Lozano, Andres M.
    Fasano, Alfonso
    Popovic, Milos R.
    Hutchison, William D.
    BRAIN, 2018, 141 : 177 - 190
  • [50] Analytical aspects of molecular Alzheimer's disease biomarkers
    Andreasson, Ulf
    Vanmechelen, Eugeen
    Shaw, Leslie M.
    Zetterberg, Henrik
    Vanderstichele, Hugo
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 377 - 389